Literature DB >> 22914174

NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.

William van der Touw1, Bryna Burrell, Girdhari Lal, Jonathan S Bromberg.   

Abstract

BACKGROUND: The role of natural killer (NK) cells in organ transplantation is poorly understood because studies link these cells to both regulatory and inflammatory functions. NK cells exacerbate inflammation and adaptive immunity under conditions of allograft rejection, but little is known regarding their roles in allograft tolerance. We test the hypothesis that NK cells have regulatory function and promote tolerance induction to murine cardiac allografts.
METHODS: Murine hearts were transplanted as fully vascularized heterotopic grafts from BALB/c donors into C57BL/6 recipients. Allograft tolerance was achieved using donor splenocyte transfusion + anti-CD40L monoclonal antibody (mAb) before transplantation. The requirement for NK cells in tolerance induction was tested by administering anti-NK1.1-depleting mAb or anti-NKG2D-blocking mAb. Intragraft and peripheral immune cell populations were determined by flow cytometry and immunohistochemistry. CD4 T-cell alloantigen-specific responses and donor-specific alloantibody were also determined.
RESULTS: NK cell-depleted recipients acutely reject allografts despite anti-CD40L blockade, but rejecting recipients lacked alloantibody and alloantigen-specific CD4 T-cell responses. NK cell depletion resulted in elevated numbers of graft-infiltrating macrophages. NKG2D blockade in tolerized recipients did not cause acute rejection but increased macrophage graft infiltration and increased the expression of NKG2D ligand Rae-1γ on these cells.
CONCLUSIONS: Our data show that NK cells are required for tolerance induction in recipients given donor splenocyte transfusion + anti-CD40L mAb. Our data suggest NK cells regulate monocyte or macrophage activation and infiltration into allografts by a mechanism partially dependent on NKG2D receptor-ligand interactions between NK cells and monocytes/macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914174      PMCID: PMC3448808          DOI: 10.1097/TP.0b013e318264d3c4

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  47 in total

1.  Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice.

Authors:  S Maier; C Tertilt; N Chambron; K Gerauer; N Hüser; C D Heidecke; K Pfeffer
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.

Authors:  K I Seino; K Fukao; K Muramoto; K Yanagisawa; Y Takada; S Kakuta; Y Iwakura; L Van Kaer; K Takeda; T Nakayama; M Taniguchi; H Bashuda; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

3.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

4.  NK cells regulate CD4 responses prior to antigen encounter.

Authors:  Kennichi C Dowdell; Daniel J Cua; Erlinda Kirkman; Stephen A Stohlman
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

5.  Targeting of human dendritic cells by autologous NK cells.

Authors:  J L Wilson; L C Heffler; J Charo; A Scheynius; M T Bejarano; H G Ljunggren
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells.

Authors:  T Kondo; K Morita; Y Watarai; M B Auerbach; D D Taub; A C Novick; H Toma; R L Fairchild
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

7.  NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen.

Authors:  Ramakrishna Vankayalapati; Peter Klucar; Benjamin Wizel; Stephen E Weis; Buka Samten; Hassan Safi; Homayoun Shams; Peter F Barnes
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Macrophages act as effectors of tissue damage in acute renal allograft rejection.

Authors:  Matthew D Jose; Yohei Ikezumi; Nico van Rooijen; Robert C Atkins; Steven J Chadban
Journal:  Transplantation       Date:  2003-10-15       Impact factor: 4.939

9.  Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Authors:  Allan D Kirk; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Steven C Hoffmann; Robert L Kampen; Linda K Cendales; Douglas K Tadaki; David M Harlan; S John Swanson
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

10.  Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

Authors:  Diego Piccioli; Silverio Sbrana; Emiliano Melandri; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  12 in total

Review 1.  Lymphodepletional strategies in transplantation.

Authors:  Eugenia Page; Jean Kwun; Byoungchol Oh; Stuart Knechtle
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 2.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 3.  T Cells Going Innate.

Authors:  Midas Seyda; Abdallah Elkhal; Markus Quante; Christine S Falk; Stefan G Tullius
Journal:  Trends Immunol       Date:  2016-07-08       Impact factor: 16.687

4.  Regulatory B Cell-Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent.

Authors:  C Schuetz; K M Lee; R Scott; L Kojima; L Washburn; L Liu; W-H Liu; H Tector; J Lei; H Yeh; J I Kim; J F Markmann
Journal:  Am J Transplant       Date:  2017-04-11       Impact factor: 8.086

5.  Bronchial epithelial injury in the context of alloimmunity promotes lymphocytic bronchiolitis through hyaluronan expression.

Authors:  Vandy P Stober; Christopher Szczesniak; Quiana Childress; Rebecca L Heise; Carl Bortner; John W Hollingsworth; Isabel P Neuringer; Scott M Palmer; Stavros Garantziotis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-18       Impact factor: 5.464

6.  IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance.

Authors:  Girdhari Lal; Neeraja Kulkarni; Yumi Nakayama; Amit K Singh; Apoorva Sethi; Bryna E Burrell; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Thomas Hehlgans; Jonathan S Bromberg
Journal:  Immunol Lett       Date:  2016-01-06       Impact factor: 3.685

Review 7.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

8.  Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.

Authors:  Cornelia Fabritius; Paul Viktor Ritschl; Thomas Resch; Mario Roth; Susanne Ebner; Julia Günther; Vanessa Mellitzer; Anh-Vu Nguyen; Johann Pratschke; Martina Sauter; Karin Klingel; Katja Kotsch
Journal:  Am J Transplant       Date:  2017-09-09       Impact factor: 8.086

9.  Mucosal Vaccination Primes NK Cell-Dependent Development of CD8+ T Cells Against Pulmonary Brucella Infection.

Authors:  Ella Bhagyaraj; Hongbin Wang; Xinghong Yang; Carol Hoffman; Ali Akgul; Zakia I Goodwin; David W Pascual
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 10.  Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage.

Authors:  Priscila de Matos Silva; Julia Bier; Lisiery Negrini Paiatto; Cassia Galdino Albuquerque; Caique Lopes Souza; Luis Gustavo Romani Fernandes; Wirla Maria da Silva Cunha Tamashiro; Patricia Ucelli Simioni
Journal:  J Immunol Res       Date:  2015-10-12       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.